New IVIG treatment aims to boost platelets in bleeding disorder
NCT ID NCT06962631
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether V-IMMUNE, a human immunoglobulin given through a vein, can safely raise platelet counts in people with immune thrombocytopenia (ITP). About 31 adults and children aged 1 year and older with very low platelets will receive two daily infusions. The main goal is to see if platelets reach a safe level within 9 days.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
V-IMMUNE (human immunoglobulin given intravenously)
What this could lead to
If successful, this could provide a safe and effective treatment option to quickly raise platelet counts and reduce bleeding risk in people with immune thrombocytopenia.
What could go wrong
This is a small, single-group study comparing results to historical data, not a placebo-controlled trial. The treatment may not work for everyone and carries risks like infusion reactions or blood clots.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNE THROMBOCYTOPENIA (ITP) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
IMIP Instituto de Medicina Integral Professor Fernando Figueira
NOT_YET_RECRUITINGRecife, Pernambuco, 50070-902, Brazil
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Santa Casa de Misericórida de São Paulo
RECRUITINGSão Paulo, São Paulo, 01221020, Brazil
Contact Phone: •••-•••-•••• Email: •••••@•••••